325 related articles for article (PubMed ID: 22119814)
1. The utility of CD44, CD117 and CD133 in identification of cancer stem cells (CSC) in oral squamous cell carcinomas (OSCC).
Mărgăritescu C; Pirici D; Simionescu C; Stepan A
Rom J Morphol Embryol; 2011; 52(3 Suppl):985-93. PubMed ID: 22119814
[TBL] [Abstract][Full Text] [Related]
2. Detection of putative stem cell markers, CD44/CD133, in primary and lymph node metastases in head and neck squamous cell carcinomas. A preliminary immunohistochemical and in vitro study.
Mannelli G; Magnelli L; Deganello A; Busoni M; Meccariello G; Parrinello G; Gallo O
Clin Otolaryngol; 2015 Aug; 40(4):312-20. PubMed ID: 25641707
[TBL] [Abstract][Full Text] [Related]
3. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
[TBL] [Abstract][Full Text] [Related]
4. CD44+/CD133+ immunophenotype and matrix metalloproteinase-9: Influence on prognosis in early-stage oral squamous cell carcinoma.
Oliveira LR; Castilho-Fernandes A; Oliveira-Costa JP; Soares FA; Zucoloto S; Ribeiro-Silva A
Head Neck; 2014 Dec; 36(12):1718-26. PubMed ID: 24178866
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD133 and CD117 in 64 Serous Ovarian Cancer Cases.
Stemberger-Papić S; Vrdoljak-Mozetic D; Ostojić DV; Rubesa-Mihaljević R; Krigtofić I; Brncić-Fisher A; Kragević M; Eminović S
Coll Antropol; 2015 Sep; 39(3):745-53. PubMed ID: 26898076
[TBL] [Abstract][Full Text] [Related]
6. CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma.
Ghuwalewala S; Ghatak D; Das P; Dey S; Sarkar S; Alam N; Panda CK; Roychoudhury S
Stem Cell Res; 2016 Mar; 16(2):405-17. PubMed ID: 26926234
[TBL] [Abstract][Full Text] [Related]
7. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.
Chiou SH; Yu CC; Huang CY; Lin SC; Liu CJ; Tsai TH; Chou SH; Chien CS; Ku HH; Lo JF
Clin Cancer Res; 2008 Jul; 14(13):4085-95. PubMed ID: 18593985
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of cancer stem cell related markers CD44 and CD133 in endometrial cancer.
Elbasateeny SS; Salem AA; Abdelsalam WA; Salem RA
Pathol Res Pract; 2016 Jan; 212(1):10-6. PubMed ID: 26608413
[TBL] [Abstract][Full Text] [Related]
9. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
[TBL] [Abstract][Full Text] [Related]
10. A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy.
Zhang Q; Shi S; Yen Y; Brown J; Ta JQ; Le AD
Cancer Lett; 2010 Mar; 289(2):151-60. PubMed ID: 19748175
[TBL] [Abstract][Full Text] [Related]
11. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
Sun L; Feng J; Ma L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of CD133(+)/CD44(+) in human colon cancer and liver metastasis.
Bellizzi A; Sebastian S; Ceglia P; Centonze M; Divella R; Manzillo EF; Azzariti A; Silvestris N; Montemurro S; Caliandro C; De Luca R; Cicero G; Rizzo S; Russo A; Quaranta M; Simone G; Paradiso A
J Cell Physiol; 2013 Feb; 228(2):408-15. PubMed ID: 22740326
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.
Soeda A; Park M; Lee D; Mintz A; Androutsellis-Theotokis A; McKay RD; Engh J; Iwama T; Kunisada T; Kassam AB; Pollack IF; Park DM
Oncogene; 2009 Nov; 28(45):3949-59. PubMed ID: 19718046
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of CD133 and musashi-1 in preneoplastic and neoplastic human oral squamous epithelium and their correlation with clinicopathological factors.
Ravindran G; Devaraj H
Head Neck; 2012 Aug; 34(8):1129-35. PubMed ID: 22076906
[TBL] [Abstract][Full Text] [Related]
17. CD44+ cancer cell-induced metastasis: A feasible neck metastasis model.
Wu TF; Chen L; Bu LL; Gao J; Zhang WF; Jia J
Eur J Pharm Sci; 2017 Apr; 101():243-250. PubMed ID: 28215944
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of microRna-200c in CD44+CD133+ CSCS inhibits the cellular migratory and invasion as well as tumorigenicity in mice.
Dou J; He XF; Cao WH; Zhao FS; Wang XY; Liu YR; Wang J
Cell Mol Biol (Noisy-le-grand); 2013 Oct; Suppl 59():OL1861-8. PubMed ID: 24120113
[TBL] [Abstract][Full Text] [Related]
19. High CD133 expression levels in gastrointestinal stromal tumors.
Bozzi F; Conca E; Manenti G; Negri T; Brich S; Gronchi A; Pierotti MA; Tamborini E; Pilotti S
Cytometry B Clin Cytom; 2011; 80(4):238-47. PubMed ID: 21462307
[TBL] [Abstract][Full Text] [Related]
20. Expression of cancer stem cell marker during 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.
Lim W; Choi H; Kim J; Kim S; Jeon S; Ni K; Song SY; Oh HK; Im Y; Lee G; Lee JY; Moon YL; You JW; Kim O
J Mol Histol; 2014 Dec; 45(6):653-63. PubMed ID: 25001207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]